Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-075528
Filing Date
2026-07-06
Accepted
2026-07-06 16:30:06
Documents
3
Period of Report
2026-07-06

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0296876-6k_chinasxt.htm 6-K 22312
2 FORM OF SECURITIES PURCHASE AGREEMENT, DATED JULY 3, 2026, BETWEEN CHINA SXT PHA ea029687601ex10-1.htm EX-10.1 240574
3 PLACEMENT AGENCY AGREEMENT, DATED JULY 3, 2026, BETWEEN CHINA SXT PHARMACEUTICAL ea029687601ex10-2.htm EX-10.2 178359
  Complete submission text file 0001213900-26-075528.txt   442339
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU China
Business Address 178 TAIDONG ROAD NORTH TAIZHOU China 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 261156306
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)